TY - JOUR
T1 - An Italian Neurology Outpatient Clinic Facing SARS-CoV-2 Pandemic: Data From 2,167 Patients
AU - Piano, Carla
AU - Di Stasio, Enrico
AU - Primiano, Guido Alessandro
AU - Janiri, Delfina
AU - Luigetti, Marco
AU - Frisullo, Giovanni
AU - Vollono, Catello
AU - Lucchini, Matteo
AU - Brunetti, Valerio
AU - Monforte, Mauro
AU - Guglielmi, Valeria
AU - Della Marca, Giacomo
AU - Evoli Stampanoni-B, Amelia
AU - Marra, Camillo
AU - Mirabella, Massimiliano
AU - Quaranta, Davide
AU - Ricci, Enzo
AU - Servidei, Serenella
AU - Silvestri, Gabriella
AU - Bellavia, Simone
AU - Bortolani, Sara
AU - Bove, Francesco
AU - Di Iorio, Riccardo
AU - Di Paolantonio, Andrea
AU - Genovese, Danilo
AU - Ialongo, Tamara
AU - Lo Monaco, Maria Rita
AU - Marotta, Jessica
AU - Patanella, Agata Katia
AU - Perna, Alessia
AU - Petracca, Martina
AU - Presicce, Giorgia
AU - Riso, Vittorio
AU - Rollo, Eleonora
AU - Romano, Angela
AU - Romozzi, Marina
AU - Sancricca, Cristina
AU - Scala, Irene
AU - Spagni, Gregorio
AU - Solito, Marcella
AU - Tricoli, Luca
AU - Zinzi, Paola
AU - Calabresi, Paolo
AU - Bentivoglio, Anna Rita
PY - 2020
Y1 - 2020
N2 - Objective: Neurological sequelae of SARS-CoV-2 infection have already been reported, but there is insufficient data about the impact of the pandemic on the management of the patients with chronic neurological diseases. We aim to analyze the effect of COVID-19 pandemic and social restriction rules on these fragile patients. Methods: Patients with chronic neurologic diseases routinely followed at the outpatient clinic of Gemelli University Hospital, Rome, were assessed for symptoms suggestive of SARS-CoV-2 infection in the pandemic period, consequences of social restrictions, and neurological disease features, concomitant medical conditions, current medical and disease-specific treatments. Data source: a dedicated telephone survey designed to encompass questions on COVID-19 symptoms and on pandemic effects in chronic neurologic conditions. Results: Overall, 2,167 individuals were analyzed: 63 patients reported contact with COVID-19 positive cases, 41 performed the swab, and 2 symptomatic patients tested positive for COVID-19 (0.09%). One hundred fifty-eight individuals (7%) needed urgent neurological care, deferred due to the pandemic; 641 patients (30%) suspended hospital treatments, physiotherapy or other support interventions; 405 individuals (19%) reported a subjective worsening of neurological symptoms. Conclusions: In our population, the presence of neurological chronic diseases did not increase the prevalence of COVID-19 infection. Nevertheless, the burden of neurological disorders has been worsened by the lockdown.
AB - Objective: Neurological sequelae of SARS-CoV-2 infection have already been reported, but there is insufficient data about the impact of the pandemic on the management of the patients with chronic neurological diseases. We aim to analyze the effect of COVID-19 pandemic and social restriction rules on these fragile patients. Methods: Patients with chronic neurologic diseases routinely followed at the outpatient clinic of Gemelli University Hospital, Rome, were assessed for symptoms suggestive of SARS-CoV-2 infection in the pandemic period, consequences of social restrictions, and neurological disease features, concomitant medical conditions, current medical and disease-specific treatments. Data source: a dedicated telephone survey designed to encompass questions on COVID-19 symptoms and on pandemic effects in chronic neurologic conditions. Results: Overall, 2,167 individuals were analyzed: 63 patients reported contact with COVID-19 positive cases, 41 performed the swab, and 2 symptomatic patients tested positive for COVID-19 (0.09%). One hundred fifty-eight individuals (7%) needed urgent neurological care, deferred due to the pandemic; 641 patients (30%) suspended hospital treatments, physiotherapy or other support interventions; 405 individuals (19%) reported a subjective worsening of neurological symptoms. Conclusions: In our population, the presence of neurological chronic diseases did not increase the prevalence of COVID-19 infection. Nevertheless, the burden of neurological disorders has been worsened by the lockdown.
KW - COVID-19
KW - coronavirus
KW - health care
KW - infection
KW - neurology
KW - pandemic
KW - personalized medicine
KW - COVID-19
KW - coronavirus
KW - health care
KW - infection
KW - neurology
KW - pandemic
KW - personalized medicine
UR - http://hdl.handle.net/10807/161608
U2 - 10.3389/fneur.2020.00564
DO - 10.3389/fneur.2020.00564
M3 - Article
SN - 1664-2295
VL - 11
SP - N/A-N/A
JO - Frontiers in Neurology
JF - Frontiers in Neurology
ER -